Quick Answer
GOLDENWELL BIOTECH, INC. reported Shares Outstanding of 99.00 million shares for fiscal year 2024.
GOLDENWELL BIOTECH, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 99.00M | +0.0% |
| 2023 | 99.00M | +0.0% |
| 2022 | 99.00M | +8.2% |
| 2021 | 91.50M | +0.0% |
| 2020 | 91.50M | +14.4% |
| 2019 | 80.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 99.00M | +0.0% | +0.0% |
| June 30, 2025 | 99.00M | +0.0% | +0.0% |
| March 31, 2025 | 99.00M | +0.0% | +0.0% |
| December 31, 2024 | 99.00M | +0.0% | +0.0% |
| September 30, 2024 | 99.00M | +0.0% | +0.0% |
| June 30, 2024 | 99.00M | +0.0% | +0.0% |
| March 31, 2024 | 99.00M | +0.0% | +0.0% |
| December 31, 2023 | 99.00M | +0.0% | +0.0% |
- GOLDENWELL BIOTECH, INC. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2024 period, GOLDENWELL BIOTECH, INC.’s shares outstanding has grown by 23.8% (from 80.00 million shares to 99.00 million shares).
- The most recent figure is from GOLDENWELL BIOTECH, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: